Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Encapsulate
AddedFeb 16, 2024
UpdatedJun 18, 2026
Encapsulate

Encapsulate

Seed

Provider of automated tumor-on-chip systems for effective cancer drug testing and treatment.

HQ
Farmington, NM, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Encapsulate was founded with the mission to revolutionize cancer treatment through precision diagnostics. The company develops automated tumor-on-a-chip systems that simulate the clinical response of cancer patients, enabling effective testing of cancer drugs. Their technology aims to provide personalized treatment plans for oncologists and patients, focusing on various cancers including colorectal, pancreatic, breast, and lung cancer. Encapsulate's core vision is to enhance the efficacy of cancer treatments and improve patient outcomes through innovative diagnostic tools.

Notable figures affiliated with Encapsulate include leading oncologists and researchers in the field of cancer diagnostics. The company has garnered attention from prominent investors in the healthcare and biotech sectors. Key achievements include successful clinical trials and partnerships with major pharmaceutical companies for drug efficacy testing. Encapsulate's impact is seen in its contribution to personalized medicine, offering a more tailored approach to cancer treatment and potentially increasing survival rates for patients worldwide.

Encapsulate - Similar Companies

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Encapsule Medical logo

Encapsule Medical

encapsule.com

Empiri logo

Empiri

empiricancer.com

Encapsio logo

Encapsio

Haploscope logo

Haploscope

haploscope.com

Epi One logo

Epi One

epi-one.com

Emulate logo

Emulate

emulatebio.com

BioSapien logo

BioSapien

biosapien.com

Encellin logo

Encellin

encellin.com

Oncobox logo

Oncobox

oncobox.com

Vesselon logo

Vesselon

vesselon.com

OncoLens logo

OncoLens

oncolens.com

Novasenta logo

Novasenta

novasenta.com

Cure Forward logo

Cure Forward

Oncodea logo

Oncodea

oncodea.com

Encapsulate - Quick Facts

Who are Encapsulate's competitors?

Companies similar to Encapsulate include OncoPrecision, Encapsule Medical, Empiri and Encapsio.

When was Encapsulate founded?

Encapsulate was founded in 2018.

Where is Encapsulate's headquarters located?

Encapsulate's headquarters is located in Farmington, NM, US.

How much has Encapsulate raised to-date?

As of May 24, 2023, Encapsulate has raised a total of $1.8M (USD).

How many employees does Encapsulate have?

Encapsulate has 5 employees as of Feb 4, 2024.

Encapsulate - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Tumor-On-Chip Systems
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities